Back to SNDX
FINANCIAL CONSULATE, INC → SNDX
FINANCIAL CONSULATE, INC SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
3
Latest value
$282
Q3 2026
Peak value
$351
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $351 |
| Q2 2026 | $328 |
| Q3 2026 | $282 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $282 | 15 | — | — |
| Q2 2026 | $328 | 15 | — | — |
| Q1 2026 | $351 | 15 | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M